US slashes vaccine schedule; Every drug approval from 2025; argenx’s new CEO; and more
US slashes vaccine schedule; Every drug approval from 2025; argenx’s new CEO; and more
US slashes vaccine schedule; Every drug approval from 2025; argenx’s new CEO; and more
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page